Mxi 1 Inhibitors
Chemical inhibitors of Mxi1 function by modulating the acetylation status of histones, a post-translational modification that plays a crucial role in regulating chromatin structure and gene expression. Trichostatin A, Vorinostat, Sodium Butyrate, Romidepsin, Panobinostat, Belinostat, Valproic Acid, Entinostat, Mocetinostat, Tacedinaline, Chidamide, and Givinostat are all identified as inhibitors that can alter the activity of histone deacetylases (HDACs). These inhibitors can increase the acetylation levels of histones, which in turn can affect the ability of Mxi1 to bind to chromatin and repress transcription. The increased acetylation caused by these inhibitors leads to a less compact chromatin structure, typically associated with active gene transcription, which can counteract the repressive effects of Mxi1 on gene expression.
The action of HDAC inhibitors on Mxi1 involves the disruption of the protein's normal interaction with its target genes. The change in chromatin structure due to histone hyperacetylation can prevent Mxi1 from effectively binding to DNA sequences it usually targets for transcriptional repression. This inhibition of Mxi1's binding capacity can result in a functional inhibition of its regulatory role in gene expression. Such alterations in the chromatin landscape where Mxi1 operates may impede its ability to modulate gene expression, thus inhibiting the actions of this protein that rely on the recruitment of co-repressor complexes and the subsequent deacetylation of histones. The inhibitors mentioned, by modifying the histone acetylation patterns, can play a role in regulating the function of Mxi1, influencing the expression of genes under its control.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylase (HDAC), which can lead to the hyperacetylation of histones, affecting the chromatin structure and potentially reducing the transcriptional repression activity of Mxi1 on target genes. By inhibiting HDAC, the structure of chromatin is altered in a way that can prevent Mxi1 from binding to its target DNA sequences, thereby functionally inhibiting Mxi1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, another HDAC inhibitor, would similarly lead to increased acetylation of histones. This could impede the repressive function of Mxi1 on its target genes by altering the chromatin structure and accessibility, thus hindering Mxi1's ability to effectively bind to its target DNA sequences and exert its repressive effects. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate acts as an HDAC inhibitor, increasing the acetylation of histones and potentially disrupting the transcriptional repression imposed by Mxi1. The alteration in chromatin structure could inhibit Mxi1's ability to bind to its target genes, leading to a functional inhibition of its regulatory effects on gene expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin functions as an HDAC inhibitor, which can modify chromatin structure by increasing histone acetylation levels. This change could impair the repressive functions of Mxi1 by altering chromatin in a manner that disrupts Mxi1's capacity to bind to its target DNA sequences. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is an HDAC inhibitor that could potentially interfere with Mxi1's ability to repress transcription by causing hyperacetylation of histones. This would lead to a more open chromatin conformation that might inhibit Mxi1's binding to its target sequences, thus functionally inhibiting its activity. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat, by inhibiting HDAC activity, can result in increased histone acetylation, potentially obstructing Mxi1's repressive interactions with chromatin. This could lead to a functional inhibition of Mxi1 by preventing its normal binding and repressive activity on target gene promoters. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, as an HDAC inhibitor, would increase histone acetylation and potentially limit the repressive functions of Mxi1 by changing the accessibility of the chromatin structure. This might prevent Mxi1 from effectively binding to and repressing its target genes. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat selectively inhibits class I HDACs, leading to histone hyperacetylation which could hinder the ability of Mxi1 to repress transcription by altering chromatin structure and DNA accessibility, thus functionally inhibiting Mxi1. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat targets HDACs, increasing acetylation of histones and potentially disrupting Mxi1's interaction with chromatin. The resulting alteration in chromatin conformation could inhibit the transcriptional repression capabilities of Mxi1, functionally inhibiting it. | ||||||
CI 994 | 112522-64-2 | sc-205245 sc-205245A | 10 mg 50 mg | $99.00 $536.00 | 1 | |
Tacedinaline is an HDAC inhibitor that could interfere with Mxi1's repressive function by causing an increase in histone acetylation, altering the chromatin structure and inhibiting Mxi1's ability to bind to its target DNA sequences. | ||||||